✦ LIBER ✦

Dose escalation study of carboplatin (CBDCA) and etoposide (VP-16) with G-CSF in small cell lung cancer (SCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin (CBDCA) plus etoposide (VP-1

✍ Bernardo, G.; Bernardo, A.; Plastina, M.; Strada, M.R.; Brunetti, G.; Pozzi, U.; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Phase I study of carboplatin, epirubicin

✍ Gridelli, C.; D'Aprile, M.; Palmeri, S.; Curcio, C.; Gebbia, V.; Veltri, E.; Ian 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Phase I–II study of carboplatin, epirubi

✍ Gridelli, C.; D'Aprile, M.; Palmeri, S.; Curcio, C.; Gebbia, V.; Veltri, E.; Ian 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Carboplatin (CBDOA) plus etoposide (VP16

✍ Crinò, L.; De Marinis, F.; Clerici, M.; Meacci, M.; Cocconi, G.; Malacarne, P.; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Etoposide (VP-16) and carboplatin as a f

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Etoposide and high dose carboplatin in p

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 147 KB